Cargando…
A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility
BACKGROUND: Differential DNA methylation panel derived from peripheral blood could serve as biomarkers of CRC susceptibility. However, most of the previous studies utilized post-diagnostic blood DNA which may be markers of disease rather than susceptibility. In addition, only a few studies have eval...
Autores principales: | Onwuka, Justina Ucheojor, Li, Dapeng, Liu, Yupeng, Huang, Hao, Xu, Jing, Liu, Ying, Zhang, Yuanyuan, Zhao, Yashuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382833/ https://www.ncbi.nlm.nih.gov/pubmed/32711505 http://dx.doi.org/10.1186/s12885-020-07194-5 |
Ejemplares similares
-
Androgen receptor gene methylation related to colorectal cancer risk
por: Xia, Tingting, et al.
Publicado: (2019) -
Integrative Analysis of Identifying Methylation-Driven Genes Signature Predicts Prognosis in Colorectal Carcinoma
por: Huang, Hao, et al.
Publicado: (2021) -
Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer
por: Li, DaPeng, et al.
Publicado: (2019) -
Methylation of a panel of genes in peripheral blood leukocytes is associated with colorectal cancer
por: Luo, Xiang, et al.
Publicado: (2016) -
Colorectal cancer patients with CASK promotor heterogeneous and homogeneous methylation display different prognosis
por: Liu, Ying, et al.
Publicado: (2020)